Contact With or Exposure to Human Immunodeficiency Virus

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Contact With or Exposure to Human Immunodeficiency Virus trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07497594

ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention

The goal of this study is to learn how well long-acting lenacapavir works to prevent human immunodeficiency virus (HIV) infection in people at higher risk of ge…

Brazil1,500 participantsStarted 2026-02-03

Treatment: Lenacapavir long-acting, Tenofovi-Emtricitabine (TDF/FTC) tablet

All recent trials (2 shown)

CompletedPhase 3

NCT02998320

Evaluation of Compliance With Treatment by Genvoya in HIV Post-exposure Prophylaxis

This study measures the proportion of enrolled patients taking the uninterrupted HIV post-exposure prophylaxis Genvoya for four weeks

France101 participantsStarted 2017-03-10

Treatment: Genvoya